ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Infection"

  • 2019 American Transplant Congress

    Donor-Derived Cell-Free DNA in Urine Identifies BKVN with Graft Injury in BK Viruria Kidney Transplant Recipients

    G. Huang1, X. Chen1, S. Yang2, W. Chen2, P. Chen3, X. Hou4, T. Jiang5, H. Liu5, X. Li5, C. Wang1

    1Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 2Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 3Department of clinical laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 4Guangzhou KingMed Center for Clinical Laboratory Co.,Ltd., Guangzhou, China, 5Research and Development, AlloDx Biotech Co.Ltd., Suzhou, China

    *Purpose: BK Polyomavirus nephropathy (BKVN) is an important cause of dysfunction and failure of renal transplants. Elevated levels of donor-derived cell-free DNA (dd-cfDNA) in the…
  • 2019 American Transplant Congress

    Infectious Complications in Kidney Transplant Recipients Age 65 and Older

    L. E. Liriano-Ward1, M. Barbachan e Silva2, Y. Azzi1, M. Ajaimy1, A. Cambell1, J. Graham1, J. Rocca1, C. Pynadath1, G. Nair1, O. Andacoglu1, S. Greenstein1, P. Ó Broin2, E. Akalin1

    1Transplant, Einstein/Montefiore Medical Center, Bronx, NY, 2School of Mathematics, Statistics & Applied Mathematics, National University of Ireland Galway, Galway, Ireland

    *Purpose: Kidney transplant recipients age 65 years and older are at higher risk for development of infections. We aimed to investigate the incidence of both…
  • 2019 American Transplant Congress

    Induction Therapy in Elderly Kidney Transplant Recipients with Low Immunological Risk

    C. Masset1, J. Boucquemont2, V. Garrigue3, M. Ladrière4, F. Buron5, E. Cassuto6, Y. Foucher2, J. Dantal1

    1University Hospital of Nantes, Nantes, France, 2University of Nantes, Nantes, France, 3University Hospital of Montpellier, Montpellier, France, 4University Hospital of Nancy, Nancy, France, 5University Hospital of Lyon, Lyon, France, 6University Hospital of Nice, Nice, France

    *Purpose: Thymoglobulin (ATG) and Basiliximab (BSX) lead to similar rejection rates in low immunological risk patients. ATG seems to be associated with infectious and malignancy…
  • 2019 American Transplant Congress

    Effect of Influenza Vaccine in Patients with Kidney Transplant during 2017/2018

    K. Tsujimura1, M. Ota1, H. Ishida2, K. Tanabe2

    1Surgery, Tomishiro Central Hospital, Okinawa, Japan, 2Urology, Tokyo Women's Medical University, Tokyo, Japan

    *Purpose: This study aimed to evaluate the effect of influenza vaccine in kidney transplant recipients during the 2017/2018.*Methods: We retrospectively assessed 136 patients who underwent…
  • 2019 American Transplant Congress

    Infectious Complications after Treatment of Antibody-Mediated Kidney Allograft Rejection: A National Cohort Study

    N. Perrottet1, D. Golshayan2, O. Manuel2, V. Aubert2, M. Koller3, K. Hadaya4, L. Bühler4, T. Mueller5, U. Huynh-Do6, S. Dahdal6, I. Binet7, M. Dickenmann3, S. Schaub3, J. Steiger3, M. Pascual2, M. Fernández-Ruiz2

    1Pharmacy, CHUV, Lausanne, Switzerland, 2CHUV, Lausanne, Switzerland, 3USB, Basel, Switzerland, 4HUG, Geneva, Switzerland, 5USZ, Zurich, Switzerland, 6Inselspital, Bern, Switzerland, 7KSSG, St. Gallen, Switzerland

    *Purpose: Multimodal therapeutic strategies used to treat acute antibody-mediated rejection (AMR) could enhance the risk of infection. However, data in this context are scarce.*Methods: We…
  • 2019 American Transplant Congress

    Assessment of Serum Tim3 and Gal9 Levels in Predicting the Risk of Infection after Kidney Transplantation

    Y. Shi1, y. li2, Y. Li2, L. Yan2, J. Tang2, X. Wu2, Y. Bai2, Y. An2, B. Dai2, C. Yang2, L. Wang2

    1Department of Nephrology, West China Hospital, Chengdu, China, 2Department of Laboratory Medicine, West China Hospital, Chengdu, China

    *Purpose: Infection remains a major cause of morbidity and mortality after kidney transplantation (KT). However, reliable biomarkers to predict the occurrence of post-transplant infection are…
  • 2019 American Transplant Congress

    Gut Microbiome And Acute Rejection After Kidney Transplantation

    H. Cho1, Y. Yang1, J. Kim2, J. Moon2, J. Jeong2, J. Park3, M. Kwak4, B. Kim4, D. Kim2, J. Lee5, B. Kim6, Y. Kim2, H. Lee2

    1Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea, Republic of, 2Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, 3Internal Medicine, Kangwon National University Hospital, Chuncheon, Korea, Republic of, 4ChunLab Inc., Seoul, Korea, Republic of, 5Internal Medicine, Seoul National University, Boramae Hospital, Seoul, Korea, Republic of, 6Hallym University, Chuncheon, Korea, Republic of

    *Purpose: Acute rejection (AR) is a common complication in kidney transplantation (KT) and associated with reduced patient-graft survival. Recent studies have shown that the gut…
  • 2019 American Transplant Congress

    Treatment of Pseudomonas Infection with Beta-Lactams Including Ceftolozane-Tazobactam in Solid Organ Transplant Recipients

    M. Henry1, J. Puvvula2, J. John Schoen1, L. Puzniak3, J. Raddatz4, T. Van Schooneveld2, S. Bergman1

    1Nebraska Medicine, Omaha, NE, 2University of Nebraska Medical Center, Omaha, NE, 3Merck & Co., Inc, Kenilworth, NJ, 4Merck & Co., Inc, Kenilworth, NJ, NJ

    *Purpose: Ceftolozane/Tazobactam (CT) is a potent anti-pseudomonal agent with broad gram-negative activity. Our academic medical center recommends the use of CT for patients with a…
  • 2019 American Transplant Congress

    Comparing the Rate of Opportunistic Infection after Renal Transplant between Alemtuzumab and Basiliximab for Induction Immunosuppression

    J. A. Seaman1, S. G. Westphal2, F. Qiu3, D. Bremers4, D. Florescu5

    1College of Medicine, University of Nebraska Medical Center, Omaha, NE, 2Internal Medicine Division of Nephrology, University of Nebraska Medical Center, Omaha, NE, 3Biostatistics, University of Nebraska Medical Center, Omaha, NE, 4Donate Life, Nebraska Medicine, Omaha, NE, 5Internal Medicine Division of Infectious Disease, University of Nebraska Medical Center, Omaha, NE

    *Purpose: The aim of our study was to compare the outcomes one-year after renal transplant with a focus on opportunistic infections in patients who received…
  • 2019 American Transplant Congress

    The Significance and Impact of Screening Preservation Fluid Cultures in Renal Transplant Recipients

    A. Reticker, A. Lichvar, A. Gross, E. Benedetti, S. Patel

    University of Illinois Hospital and Health Sciences System, Chicago, IL

    *Purpose: Preservation fluid (PF) is necessary to maintain organ viability but serves as a vector for infection. The utility of routine PF screening and impact…
  • « Previous Page
  • 1
  • …
  • 47
  • 48
  • 49
  • 50
  • 51
  • …
  • 84
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences